| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 488 |
| 1 | ASPIRIN 325 MG | 448 |
| 2 | ASPIRIN 81 MG | 448 |
| 3 | INSULIN GLARGINE | 372 |
| 4 | ADALIMUMAB | 353 |
| 5 | FUROSEMIDE | 342 |
| 6 | METOPROLOL TARTRATE | 284 |
| 7 | ETANERCEPT | 279 |
| 8 | CLOPIDOGREL | 274 |
| 9 | ATORVASTATIN CALCIUM | 265 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PSEUDOEPHEDRINE HCL | 1 | 0.1667 |
| 1 | LONAFARNIB | 3 | 0.0385 |
| 2 | RANOLAZINE | 196 | 0.0186 |
| 3 | METHSUXIMIDE | 2 | 0.0110 |
| 4 | METHENAMINE MANDELATE | 2 | 0.0107 |
| 5 | TEDIZOLID PHOSPHATE | 8 | 0.0100 |
| 6 | AAMLODIPINE AND OLMESARTAN MEDOXOMIL | 2 | 0.0098 |
| 7 | CHLOROTHIAZIDE | 12 | 0.0095 |
| 8 | 3% SODIUM CHLORIDE | 1 | 0.0088 |
| 9 | AFICAMTEN | 4 | 0.0080 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 619 |
| 1 | Insulin Analog [EPC] | 582 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 497 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 453 |
| 4 | Endothelin Receptor Antagonist [EPC] | 428 |
| 5 | PCSK9 Inhibitor [EPC] | 386 |
| 6 | Loop Diuretic [EPC] | 384 |
| 7 | Interleukin-23 Antagonist [EPC] | 374 |
| 8 | Factor Xa Inhibitor [EPC] | 361 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 265 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 45 | 0.0654 |
| 1 | Farnesyltransferase Inhibitor [EPC] | 3 | 0.0385 |
| 2 | Anti-anginal [EPC] | 196 | 0.0186 |
| 3 | PCSK9 Inhibitor [EPC] | 386 | 0.0150 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 17 | 0.0082 |
| 5 | Provitamin D2 Compound [EPC] | 201 | 0.0068 |
| 6 | Interleukin-23 Antagonist [EPC] | 374 | 0.0036 |
| 7 | Adrenocorticotropic Hormone [EPC] | 3 | 0.0034 |
| 8 | Classical Complement Pathway Inhibitor [EPC] | 1 | 0.0031 |
| 9 | Complement 5a Receptor Antagonist [EPC] | 20 | 0.0030 |